Angiogenesis inhibitors in the treatment of non-small cell lung cancer
about
Proteomic profiling of lung adenocarcinoma indicates heightened DNA repair, antioxidant mechanisms and identifies LASP1 as a potential negative predictor of survival.Sanguinarine is a novel VEGF inhibitor involved in the suppression of angiogenesis and cell migration.Azithromycin effectively inhibits tumor angiogenesis by suppressing vascular endothelial growth factor receptor 2-mediated signaling pathways in lung cancer.
P2860
Angiogenesis inhibitors in the treatment of non-small cell lung cancer
description
2009 nî lūn-bûn
@nan
2009 թուականի Սեպտեմբերին հրատարակուած գիտական յօդուած
@hyw
2009 թվականի սեպտեմբերին հրատարակված գիտական հոդված
@hy
2009年の論文
@ja
2009年論文
@yue
2009年論文
@zh-hant
2009年論文
@zh-hk
2009年論文
@zh-mo
2009年論文
@zh-tw
2009年论文
@wuu
name
Angiogenesis inhibitors in the treatment of non-small cell lung cancer
@ast
Angiogenesis inhibitors in the treatment of non-small cell lung cancer
@en
type
label
Angiogenesis inhibitors in the treatment of non-small cell lung cancer
@ast
Angiogenesis inhibitors in the treatment of non-small cell lung cancer
@en
prefLabel
Angiogenesis inhibitors in the treatment of non-small cell lung cancer
@ast
Angiogenesis inhibitors in the treatment of non-small cell lung cancer
@en
P2860
P356
P1476
Angiogenesis inhibitors in the treatment of non-small cell lung cancer
@en
P2093
Egbert F Smit
Joline S W Lind
P2860
P304
P356
10.1177/1758834009338633
P577
2009-09-01T00:00:00Z